Renaissance Technologies (RenTech)'s PAHC Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 576,735 shares of Phibro Animal Health Corporation (PAHC) worth $31.9 M, representing 0.05% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 42 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in PAHC, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2017, adding 184,316 shares. Largest reduction occurred in Q4 2020, reducing 246,000 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Phibro Animal Health Corporation (PAHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Phibro Animal Health Corporation (PAHC) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +31,435 | Add 5.76% | 576,735 | $55.31 |
| Q4 2025 | -9,900 | Reduce 1.78% | 545,300 | $37.36 |
| Q3 2025 | -55,600 | Reduce 9.10% | 555,200 | $40.46 |
| Q2 2025 | -94,500 | Reduce 13.40% | 610,800 | $25.54 |
| Q1 2025 | +147,500 | Add 26.44% | 705,300 | $21.36 |
| Q4 2024 | +10,600 | Add 1.94% | 557,800 | $21.00 |
| Q3 2024 | +20,400 | Add 3.87% | 547,200 | $22.52 |
| Q2 2024 | -200 | Reduce 0.04% | 526,800 | $16.77 |
| Q1 2024 | -47,600 | Reduce 8.28% | 527,000 | $12.93 |
| Q4 2023 | +47,900 | Add 9.09% | 574,600 | $11.58 |
| Q3 2023 | +1,200 | Add 0.23% | 526,700 | $12.77 |
| Q2 2023 | +1,500 | Add 0.29% | 525,500 | $0.01 |
| Q1 2023 | -7,700 | Reduce 1.45% | 524,000 | $0.02 |
| Q4 2022 | -9,800 | Reduce 1.81% | 531,700 | $0.01 |
| Q3 2022 | -59,400 | Reduce 9.89% | 541,500 | $13.29 |
| Q2 2022 | +1,800 | Add 0.30% | 600,900 | $19.13 |
| Q1 2022 | -38,700 | Reduce 6.07% | 599,100 | $19.95 |
| Q4 2021 | +2,500 | Add 0.39% | 637,800 | $20.42 |
| Q3 2021 | -29,900 | Reduce 4.49% | 635,300 | $21.54 |
| Q2 2021 | -41,600 | Reduce 5.89% | 665,200 | $28.88 |
| Q1 2021 | -117,200 | Reduce 14.22% | 706,800 | $24.40 |
| Q4 2020 | -246,000 | Reduce 22.99% | 824,000 | $19.42 |
| Q3 2020 | +135,000 | Add 14.44% | 1.07 M | $17.40 |
| Q2 2020 | +61,200 | Add 7.00% | 935,000 | $26.27 |
| Q1 2020 | +35,300 | Add 4.21% | 873,800 | $24.17 |
| Q4 2019 | +44,000 | Add 5.54% | 838,500 | $24.83 |
| Q3 2019 | +38,000 | Add 5.02% | 794,500 | $21.33 |
| Q2 2019 | -22,600 | Reduce 2.90% | 756,500 | $31.77 |
| Q1 2019 | -51,800 | Reduce 6.23% | 779,100 | $33.00 |
| Q4 2018 | +27,100 | Add 3.37% | 830,900 | $32.16 |
| Q3 2018 | +169,300 | Add 26.68% | 803,800 | $42.90 |
| Q2 2018 | +97,700 | Add 18.20% | 634,500 | $46.05 |
| Q1 2018 | +73,304 | Add 15.82% | 536,800 | $39.70 |
| Q4 2017 | +65,396 | Add 16.43% | 463,496 | $33.50 |
| Q3 2017 | +184,316 | Add 86.22% | 398,100 | $37.05 |
| Q2 2017 | +162,384 | Add 315.92% | 213,784 | $37.05 |
| Q1 2017 | +37,500 | Add 269.78% | 51,400 | $28.09 |
| Q4 2016 | +13,900 | New Buy | 13,900 | $29.28 |
| Q4 2015 | -89,600 | Sold Out | 0 | $0.00 |
| Q3 2015 | +41,800 | Add 87.45% | 89,600 | $31.63 |
| Q2 2015 | -3,900 | Reduce 7.54% | 47,800 | $38.93 |
| Q1 2015 | +51,700 | New Buy | 51,700 | $35.42 |
Renaissance Technologies (RenTech)'s Phibro Animal Health Corporation Investment FAQs
Renaissance Technologies (RenTech) first purchased Phibro Animal Health Corporation (PAHC) in Q1 2015, acquiring 51,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Phibro Animal Health Corporation (PAHC) for 42 quarters since Q1 2015.
Renaissance Technologies (RenTech)'s largest addition to Phibro Animal Health Corporation (PAHC) was in Q3 2017, adding 398,100 shares worth $14.75 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 576,735 shares of Phibro Animal Health Corporation (PAHC), valued at approximately $31.9 M.
As of the Q1 2026 filing, Phibro Animal Health Corporation (PAHC) represents approximately 0.05% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Phibro Animal Health Corporation (PAHC) was 1,070,000 shares, as reported at the end of Q3 2020.